Literature DB >> 8833441

Neuronal intermediate filaments.

M K Lee1, D W Cleveland.   

Abstract

Neurofilaments (NFs) are the most abundant structural components in large-diameter myelinated axons. Assembled as obligate heteropolymers requiring NF-L and substoichiometric amounts of NF-M and/or NF-H, NF investment into axons is essential for establishment of axonal caliber, itself a key determinant of conduction velocity. Use of transgenic mice to increase axonal accumulation of NFs or to express mutant NFs subunits has proven that aberrant organization or assembly of NFs is sufficient to cause disease arising from selective dysfunction and degeneration of motor neurons. Because aberrant accumulation of NFs is a common pathology in a series of motor neuron diseases-including amyotrophic lateral sclerosis-NF misaccumulation, and the resultant disruption in axonal transport, is probably a key intermediate in the pathogenesis of these diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833441     DOI: 10.1146/annurev.ne.19.030196.001155

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  115 in total

1.  Characterization of the chicken transitin gene reveals a strong relationship to the nestin intermediate filament class.

Authors:  A Napier; A Yuan; G J Cole
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

2.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 3.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord.

Authors:  C Manitt; M A Colicos; K M Thompson; E Rousselle; A C Peterson; T E Kennedy
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  Relating interactions between neurofilaments to the structure of axonal neurofilament distributions through polymer brush models.

Authors:  Sanjay Kumar; Xinghua Yin; Bruce D Trapp; Jan H Hoh; Michael E Paulaitis
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

6.  Uniform polarity microtubule assemblies imaged in native brain tissue by second-harmonic generation microscopy.

Authors:  Daniel A Dombeck; Karl A Kasischke; Harshad D Vishwasrao; Martin Ingelsson; Bradley T Hyman; Watt W Webb
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-23       Impact factor: 11.205

7.  alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Authors:  Nigel J Cairns; Kunihiro Uryu; Eileen H Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Steven E Arnold; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

8.  Failure of lower motor neuron radial outgrowth precedes retrograde degeneration in a feline model of spinal muscular atrophy.

Authors:  Erin N Wakeling; Béatrice Joussemet; Patrick Costiou; Dominique Fanuel; Philippe Moullier; Martine Barkats; John C Fyfe
Journal:  J Comp Neurol       Date:  2012-06-01       Impact factor: 3.215

9.  Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy.

Authors:  Laurence Meyer; Christine Patte-Mensah; Omar Taleb; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Life Sci       Date:  2010-04-30       Impact factor: 9.261

Review 10.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.